IDO2 and neoplasm: Second, 4T1 subcutaneous metastatic tumors received iv a NS able to produce ·O2 and CO in the tumor, which leads to tumor cell apoptosis, as well as an immune agent NLG919 that blocks the indoleamin 2,3-dioxygenase signal pathway.